KRYS שווי כולל של נכסי החברה Krystal Biotech Inc
Krystal Biotech, Inc. (KRYS) maintains its resilience through clinic partnerships and the acquisition of bioplatforms. Monitoring total assets via ROA in a sideways trend confirms resource stability, where the value 1319.51 reflects the current magnitude. Growth is driven by unique gels for correcting genetic skin defects, while breakthrough direct gene delivery methods open the path to treating previously incurable pathologies.
פילוחים אנליטיים ודוחות נתונים של חברת Krystal Corp (KRYS)
Total assets, reverse-calculated via ROA, reflect the aggregate value of Krystal Biotech, Inc. (KRYS) resources over time, neutralizing quarterly reporting time lags by accounting for currency fluctuations. By analyzing asset size through ROA, an investor can assess the financial resilience of Krystal Biotech, Inc. (KRYS) against logistical disruptions and sanction risks affecting component imports and the protection of foreign patents.